31/05/2018
D’Liver will present their Liverpass development at the investor arrangement InventIT today organized by Norinnova Technology Transfer AS and KUPA.
D'Liver has leading expertise on uptake of biopharmaceuticals in liver, particularly in Liver Sinusoidal Endothelial Cells and Kupffer Cells.
Tromsø
Vær den første som vet og la oss sende deg en e-post når D'Liver legger inn nyheter og kampanjer. Din e-postadresse vil ikke bli brukt til noe annet formål, og du kan når som helst melde deg av.
Send en melding til D'Liver:
We provide liver uptake studies and analyses within the area of drug development. We perform specialized in-depth liver uptake, distribution and metabolic and toxic assays. We deliver decision support to enhance the development of new drugs, with special emphasis on biopharmaceuticals.